Mustang Bio Files 8-K: Corporate Updates

Ticker: MBIO · Form: 8-K · Filed: Mar 5, 2025 · CIK: 1680048

Sentiment: neutral

Topics: corporate-filing, sec-filing, pharmaceuticals

TL;DR

Mustang Bio filed an 8-K on March 5, 2025, updating corporate info. Check their Waltham, MA address.

AI Summary

Mustang Bio, Inc. filed an 8-K on March 5, 2025, reporting other events and financial statements. The filing details the company's principal executive offices located at 95 Sawyer Road, Suite 110, Waltham, Massachusetts, 02453, with a contact phone number of (781) 652-4500. The company is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.

Why It Matters

This filing provides essential corporate information and updates for Mustang Bio, Inc., including its operational address and contact details, which are important for investors and stakeholders to track the company's official communications.

Risk Assessment

Risk Level: low — The filing is a routine corporate update and does not contain information that inherently increases or decreases risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Mustang Bio, Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 5, 2025.

Where are Mustang Bio, Inc.'s principal executive offices located?

Mustang Bio, Inc.'s principal executive offices are located at 95 Sawyer Road, Suite 110, Waltham, Massachusetts, 02453.

What is the telephone number for Mustang Bio, Inc.?

The registrant's telephone number, including area code, is (781) 652-4500.

In which state is Mustang Bio, Inc. incorporated?

Mustang Bio, Inc. is incorporated in Delaware.

What is the SIC code for Mustang Bio, Inc.?

The Standard Industrial Classification (SIC) code for Mustang Bio, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 5, 2025 regarding MUSTANG BIO, INC. (MBIO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing